Language Select
Varian Logo
Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen’s Rigshospitalet and Herlev Hospital
November 03, 2017

Copenhagen, Denmark, November 3, 2017 —Varian (NYSE: VAR), the world leader in radiotherapy equipment and software, has been selected to equip the greater Copenhagen region’s two radiation oncology departments with modern treatment systems over the next several years. Linear accelerators at the city’s Rigshospitalet and Herlev Hospital oncology departments will be replaced with 15 advanced Varian TrueBeam™ and Halcyon™ treatment machines and two ViewRay MRIdian® MR-Guided Linac systems, which also formed part of the tender. Varian is booking an order for the first four of the TrueBeam™ systems in the current fiscal quarter.

In a project totaling $50 million over the next several years, Varian will install TrueBeam and Halcyon devices, which feature a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. Rigshospitalet and Herlev Hospital will also install a full suite of Varian’s treatment planning and oncology information software to manage cancer patient workflow.

“We look forward to this multi-year strategic partnership with Varian which will secure our patients and hospitals with both continuous state-of-the-art technology and the benefits from a strong research collaboration,” said Lars Dahl Allerup, lead strategic buyer from corporate procurement in The Capital Region of Denmark, which owns and operates the two hospitals.

“This major investment shows the commitment of The Capital Region of Denmark and the Danish government to improving cancer care and will bring the latest in radiotherapy treatments to the country’s cancer patients,” said Kolleen Kennedy, president of Varian’s Oncology Systems business. “We are delighted that Varian has been selected to equip these projects and we look forward to continuing to provide clinicians at both hospitals with advanced systems to treat cancer patients as precisely and effectively as possible.”